JENNIFER LOOP-MILLER: Open Payments
NPI 1730698267 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 6 payments from 5 companies in 2025. Trend: 2023 $429 · 2024 $408 · 2025 $561
Food & beverage: $489Education: $71
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $218 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $71 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: INGREZZA, CAPLYTA, REXULTI, ABILIFY MAINTENA, Qelbree.
Industry payments across IN — which companies pay providers there.
